Physician profile
Donald E Bartlett
NPI 1912062142
$1,543.57
in general payments reported to CMS, 2019-2025
10 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Addiction Medicine (Family Medicine) provider received nationally (typical 2025 total: $143).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2021: $1,080 · 2024: $38.12 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $1,080.00 | 2021 | |
| Alkermes, INC. | $110.57 | 2019 | |
| Xeris Pharmaceuticals, INC. | $97.88 | 2025 | Gvoke Hypopen |
| Abbvie INC. | $82.05 | 2025 | |
| Glaxosmithkline, LLC. | $46.23 | 2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $40.70 | 2025 | Ozempic |
| Exact Sciences Corporation | $38.35 | 2024-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $18.47 | 2025 | Airsupra |
| Amgen INC. | $15.88 | 2025 | Repatha |
| Astellas Pharma US INC | $13.44 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Bartlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.